SEC Form 4 · accession 0001572426-15-000058
Nexvet Biopharma plc · NVET
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Colin Giles
Officer — VP Clinical&Regulatory Affairs
Period of report
May 18, 2015
Accepted (ET)
May 20, 2015 · 8:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618561
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase SharesF1 | $15.00 | May 18, 2015 | A | 40,000 | A | — | May 18, 2020 | Ordinary Shares | 40,000 | 40,000 | D |
Explanation of responses
- F1The Option vested and became exercisable with respect to 10,000 shares on 5/18/15, and 2,000 shares shall vest and become exercisable on each of 6/30/15, 9/30/15, 12/31/15, 3/31/16, 6/30/16, 9/30/16, 12/31/16, 3/31/17, 6/30/17, 9/30/17, 12/31/17, 3/31/18, 6/30/18, 9/30/18 and 12/31/18.